Literature DB >> 2331407

Characterization of skin lesions in mice following intradermal inoculation of Haemophilus ducreyi.

M Tuffrey1, F Alexander, R C Ballard, D Taylor-Robinson.   

Abstract

Twelve strains of H. ducreyi, which included two reference strains, were each inoculated intradermally into the flanks of CBA mice. All strains produced self-limited lesions which were macroscopically and microscopically typical of those seen in chancroid. Pustular nodules, about 5mm in diameter, developed at all inoculation sites by the second day when 10(7) organisms were inoculated. Approximately half of these lesions ulcerated and all had regressed by 2 weeks. Smaller nodules developed at about half the sites from the second to the fifth day when 10(6) or 10(5) organisms were given, but these did not ulcerate. No lesions were seen when 10(3) organisms were inoculated. Organisms were recovered from the lesions up to 11 days after inoculation. Specific H. ducreyi antigen, sought by a monoclonal antibody test, was detected in lesions up to 15 days following inoculation. Heat-killed organisms of H. ducreyi also produced nodules and ulcers although these were slightly smaller than those which developed after inoculation of viable bacteria. Similar lesions to those caused by H. ducreyi were produced after intradermal inoculation of about 10(8) viable or killed Neisseria gonorrhoeae organisms. Treatment of mice with ceftriaxone had little or no effect on the subsequent development of H. ducreyi-induced lesions. These findings indicated that the lesions were not produced specifically by viable H. ducreyi organisms. Ulcers were also produced following intradermal inoculation of purified lipopolysaccharide (LPS) from H. ducreyi or N. gonorrhoeae, but not by cell-free filtrates prepared from H. ducreyi cultures indicating a possible role for LPS in the pathogenesis of ulcerative skin lesions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2331407      PMCID: PMC1998715     

Source DB:  PubMed          Journal:  J Exp Pathol (Oxford)        ISSN: 0958-4625


  7 in total

Review 1.  Chancroid: clinical variants and other findings from an epidemic in Dallas County, 1986-1987.

Authors:  M E McCarley; P D Cruz; R D Sontheimer
Journal:  J Am Acad Dermatol       Date:  1988-08       Impact factor: 11.527

2.  Antimicrobial susceptibility of Haemophilus ducreyi.

Authors:  G W Hammond; C J Lian; J C Wilt; A R Ronald
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

3.  Improved techniques for the preparation of bacterial lipopolysaccharides.

Authors:  K G Johnson; M B Perry
Journal:  Can J Microbiol       Date:  1976-01       Impact factor: 2.419

4.  The isolation of H. ducreyi in Singapore.

Authors:  V S Rajan; E H Sng; A L Lim
Journal:  Ann Acad Med Singapore       Date:  1983-01       Impact factor: 2.473

5.  Antibiotic susceptibilities and plasmid profiles of Haemophilus ducreyi isolates from southern Africa.

Authors:  D Abeck; A P Johnson; Y Dangor; R C Ballard
Journal:  J Antimicrob Chemother       Date:  1988-10       Impact factor: 5.790

6.  Preputial abscesses caused by beta-lactamase-producing gonococci.

Authors:  U Neubert; H C Korting; C Luderschmidt; O Braun-Falco
Journal:  Cutis       Date:  1985-08

7.  Relationship between lipopolysaccharide composition and virulence of Haemophilus ducreyi.

Authors:  J A Odumeru; G M Wiseman; A R Ronald
Journal:  J Med Microbiol       Date:  1987-03       Impact factor: 2.472

  7 in total
  13 in total

1.  Identification of tandem genes involved in lipooligosaccharide expression by Haemophilus ducreyi.

Authors:  M K Stevens; J Klesney-Tait; S Lumbley; K A Walters; A M Joffe; J D Radolf; E J Hansen
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

2.  Cloning and characterization of the lipooligosaccharide galactosyltransferase II gene of Haemophilus ducreyi.

Authors:  S Sun; B Schilling; L Tarantino; M V Tullius; B W Gibson; R S Munson
Journal:  J Bacteriol       Date:  2000-04       Impact factor: 3.490

3.  Use of tissue culture and animal models to identify virulence-associated traits of Haemophilus ducreyi.

Authors:  M J Alfa; M K Stevens; P DeGagne; J Klesney-Tait; J D Radolf; E J Hansen
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

4.  The lbgAB gene cluster of Haemophilus ducreyi encodes a beta-1,4-galactosyltransferase and an alpha-1,6-DD-heptosyltransferase involved in lipooligosaccharide biosynthesis.

Authors:  Michael V Tullius; Nancy J Phillips; N Karoline Scheffler; Nicole M Samuels; Robert S Munson Jr; Eric J Hansen; Marla Stevens-Riley; Anthony A Campagnari; Bradford W Gibson
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

5.  Involvement of the Haemophilus ducreyi gmhA gene product in lipooligosaccharide expression and virulence.

Authors:  B A Bauer; M K Stevens; E J Hansen
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

6.  Molecular analysis of the Haemophilus ducreyi groE heat shock operon.

Authors:  L M Parsons; A L Waring; M Shayegani
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

Review 7.  Chancroid and Haemophilus ducreyi: an update.

Authors:  D L Trees; S A Morse
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

8.  Haemophilus ducreyi adheres to but does not invade cultured human foreskin cells.

Authors:  M J Alfa; P Degagne; T Hollyer
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

9.  Role of lipooligosaccharides in experimental dermal lesions caused by Haemophilus ducreyi.

Authors:  A A Campagnari; L M Wild; G E Griffiths; R J Karalus; M A Wirth; S M Spinola
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

10.  Investigation of the structural heterogeneity of lipooligosaccharides from pathogenic Haemophilus and Neisseria species and of R-type lipopolysaccharides from Salmonella typhimurium by electrospray mass spectrometry.

Authors:  B W Gibson; W Melaugh; N J Phillips; M A Apicella; A A Campagnari; J M Griffiss
Journal:  J Bacteriol       Date:  1993-05       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.